top of page


California 2023 Compliance Policy and Declaration 



  • As part of MicroTransponder’s ongoing efforts in compliance, we have developed a Comprehensive Compliance Program that is designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of our products. To our knowledge as of the date of this declaration, MicroTransponder is in compliance with our Comprehensive Compliance program, as described here, and with California Health & Safety Code sections 119400-119402. 

  • Copies of our Comprehensive Compliance Program CCP and our Annual Declaration of Compliance can be obtained by calling us at 855-628-9375, emailing us at, or visiting our website at

  • Last updated: 04/14/2023



  • MicroTransponder (“MicroTransponder” or “Company”) has established a program designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of its products. Additionally, MicroTransponder recognizes that adherence to these standards can be furthered through a compliance program that is informed by the Compliance Program Guidance for Pharmaceutical Manufacturers, published by the Office of Inspector General of the U.S. Department of Health and Human Services (the “OIG Guidance”). The OIG Guidance advises that effective compliance programs are comprised of seven elements, which are outlined below. As described below, these elements form the basis of the Company program for compliance with the standards regulating the marketing and promotion of its products. In addition, MicroTransponder has implemented and maintains a website ( and a compliance hotline (855-628-9375) to facilitate communication and requests for information related to California State requirements. 

  • Written Policies and Procedures 
    MicroTransponder has written policies and procedures to assure substantial compliance with the applicable laws, regulations and standards governing the marketing and promotion of our products. MicroTransponder follows the PhRMA Code on Interactions with Health Care Professionals (“PhRMA Code”). MicroTransponder has established written policies and procedures that govern activities involving communicating with health care professionals about the appropriate use of our products, including appropriate instruction and education required for the safe and effective use of our products. MicroTransponder also has policies and procedures governing activities involving the advancement of scientific and educational activities supporting medical research and education. These policies and procedures include: 

    • Policy on Educational Grants and Research Grants 
      MicroTransponder may provide grants for specific educational purposes that benefit health care professionals. These may include, but are not limited to, continuing medical and paraprofessional education programs, fellowships provided to teaching institutions and similar organizations with a demonstrated commitment to scientific and technical education, and programs operated by organizations that provide high-quality, nationally recognized education. Funding of educational programs will generally be provided only to organizations and institutions and not to individual practitioners. 
      Research grants to support physician-initiated research may be provided for programs involving research in areas of legitimate interest to the Company. All requests are subject to scientific review prior to funding approval. 

    • Policy on Charitable Contributions and Patient Assistance 
      MicroTransponder will consider charitable contributions and requests for patient assistance for costs associated with the Vivistim Paired VNS System placement procedure and rehabilitation therapy in chronic ischemic stroke patients meeting reasonable, verifiable, and uniform eligibility requirements.

    • Policy on Travel Expense Reimbursement for CME, Promotional or Product Training Meetings 
      MicroTransponder may reimburse attendees for their reasonable travel and lodging expenses associated with attendance at training meetings conducted by MicroTransponder. Training meetings will be conducted in locations conducive to the exchange of information such as educational or conference settings. Where face-to-
      face health care professionals training is reasonably necessary for the safe and effective use of MicroTransponder products is required, MicroTransponder may provide training at Company facilities, at independent teaching centers such as medical institutions, or in other appropriate clinical settings. 

    • Policy on Business Meals 
      MicroTransponder may occasionally offer a modest meal as part of an educational presentation or a business discussion. Entertainment or recreation at such meetings is not permitted. Attendance by spouses or guests at such meetings is not permitted unless the spouse or guest has a bona fide reason for attending, e.g., they are a health care professional interested in prescribing an MicroTransponder product. 

    • Policy on the Provision of Educational and Practice-Related Items 
      Subject to approval from the MicroTransponder Compliance Officer, MicroTransponder representatives may provide items that benefit patients or serve a genuine educational function for health care professionals. 

  • Total Annual Dollar Limit for Meals, Educational or Practice-Related Items Training Expenses and Expense Reimbursement for Training Meetings 
    der has established an annual limit of $2,500 for meals and educational items as the aggregate value of the items or activities that may be provided to California health care professionals pursuant to the requirements of Cal. Health & Safety Code § 119402 (S.B. 1765). 

  • Policy Prohibiting Entertainment 
    It is the policy of MicroTransponder not to provide Entertainment (e.g., sporting events, golf outings, concerts, etc.) to health care professionals. 

  • Assigned Compliance Officer 
    MicroTransponder has a Compliance Officer. Our Compliance Officer is empowered with appropriate authority to exercise independent judgment and has free and unencumbered access to senior management and board of directors. 
    MicroTransponder has a Compliance Committee. The committee is comprised of the Company’s Compliance Officer and members of the Company’s management team. 

  • Training 
    MicroTransponder has an annual Compliance Training process. New employees receive training at the time of hire and annually thereafter. The training covers applicable guidelines governing our compliance program. Employees are trained on the consequences of failure to comply with the requirements of the Company’s compliance program. 

  • Communication 
    MicroTransponder encourages open and candid discussion between management and employees regarding any compliance concern. MicroTransponder employees are encouraged to report their concerns to their manager or to the Compliance Officer. Employees also have the option to report potential violations anonymously using the MicroTransponder Compliance Hotline at 855-628-9375.

  • Auditing and Monitoring 
    MicroTransponder self-assesses and periodically audits its compliance with its policies and procedures. 

  • Enforcement and Disciplinary Guidelines 
    MicroTransponder may take disciplinary action, up to and including discharge/termination, in response to violation of the Company’s compliance policies or procedures. MicroTransponder may investigate matters that are brought to the Company’s attention to ensure the consistent application of the Company’s standards. 

  • Responses to Detected Problems and Actions to Correct Issues 
    MicroTransponder requires a prompt and diligent response to potential violations of the Company’s compliance program, including its standards regulating the marketing and promotion of our products. Actions in response to detected problems may include improving policies, procedures, training, communication and monitoring or may require disciplinary action to prevent future violations. 


bottom of page